Rescue therapy of paediatric lupus nephritis with plasma cell-directed antibodies
Authors:
- Sivakanthan KasinathanSKSivakanthan Kasinathan
- Imelda M. BalboniIBImelda M. Balboni
- Joyce HsuJHJoyce Hsu
- Paul C. GrimmPGPaul C. Grimm
- Jack YeungJYJack Yeung
- Shaun W. JacksonSJShaun W. Jackson
- William H. RobinsonWRWilliam H. Robinson
- Amanda MoyerAMAmanda Moyer
- Alice BertainaABAlice Bertaina
- Jessie L. AlexanderJAJessie L. Alexander
- Elizabeth L. ProfitaEPElizabeth L. Profita
- Joanne LeeJLJoanne Lee
- 30 October 2026
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
Abstract
No abstract availableFunding Information
- Else Kröner-Fresenius-Stiftung
- Lupus Research Alliance
- Rheumatology Research Foundation
- Boehringer Ingelheim
- Stanford Maternal and Child Health Research Institute
- National Institute of Nursing Research
- Childhood Arthritis and Rheumatology Research Alliance
- Arthritis National Research Foundation
- Lupus Foundation of America
This publication has 10 references indexed in Scilit:
- Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseasesNature Medicine, 2026
- Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trialNature Communications, 2026
- Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritisFrontiers in Immunology, 2025
- Teclistamab-Induced Remission in Refractory Systemic Lupus ErythematosusNew England Journal of Medicine, 2024
- BCMA-Targeted T-Cell–Engager Therapy for Autoimmune DiseaseNew England Journal of Medicine, 2024
- CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-upNew England Journal of Medicine, 2024
- Daratumumab monotherapy for refractory lupus nephritisNature Medicine, 2023
- Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC‐1 study of patients with relapsed/refractory multiple myelomaCancer, 2023
- Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosusNature Medicine, 2022
- Difference in disease features between childhood‐onset and adult‐onset systemic lupus erythematosusArthritis & Rheumatism, 2008